Fri, December 18, 2020
Thu, December 17, 2020
Wed, December 16, 2020
Tue, December 15, 2020
Mon, December 14, 2020
Fri, December 11, 2020
Thu, December 10, 2020
Wed, December 9, 2020
Tue, December 8, 2020
Mon, December 7, 2020

Martin Auster Maintained (SRPT) at Hold with Decreased Target to $156 on, Dec 14th, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-156-on-dec-14th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Martin Auster of Credit Suisse, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Hold with Decreased Target from $162 to $156 on, Dec 14th, 2020.

Martin has made no other calls on SRPT in the last 4 months.



There are 6 other peers that have a rating on SRPT. Out of the 6 peers that are also analyzing SRPT, 0 agree with Martin's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Martin


  • Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy and Held Target at $183 on, Monday, November 16th, 2020
  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Decreased Target to $197 on, Friday, November 6th, 2020
  • Colin Bristow of "UBS" Initiated at Strong Buy and Held Target at $212 on, Wednesday, October 28th, 2020
  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Increased Target to $190 on, Tuesday, September 15th, 2020
  • Debjit Chattopadhyay of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $221 on, Monday, August 31st, 2020
  • Danielle Brill of "Raymond James" Initiated at Buy and Held Target at $200 on, Tuesday, August 25th, 2020

Publication Contributing Sources